Maxim Group Announces Strategic Promotions in Healthcare Research

NEW YORK, NY – 5/23/2017 – Maxim Group LLC, a leading full service investment banking, securities and wealth management firm is proud to announced the enhancement of its Healthcare Equity Research practice with the promotions of Jason Kolbert to Executive Managing Director, Jason McCarthy to Managing Director, and Gabrielle Zhou to Senior Vice President.

“Jason has been successful in leveraging his wealth of experience, depth of industry knowledge and extensive relationships in the healthcare sector to create a unique research model which has created significant value for our clients. We are pleased to acknowledge his contributions to Maxim Group and his leadership in the healthcare space,” said Anthony V. Vendetti, Executive Managing Director of Equity Research. The biotechnology team which includes Jason McCarthy, PH.D, Gabrielle Zhou and their staff, currently cover over 80 research names. While each covered name has a lead analyst,
the team approach creates a collaborative effort whereby the analysts work together to apply their individual expertise to each company. The group expects to double research coverage over the next year as more resources are added to build out this important vertical.

Dr. McCarthy is being recognized for his leadership in CAR-T and Immunology, as well as his responsibilities as the Production Manager overseeing the team’s operations and coverage initiatives.

Gabrielle Zhou is being recognized for her execution of the 2017 Maxim Group – Haitong Securities Healthcare Conference in Shanghai, China. The conference featured an extensive range of public healthcare companies across the Pharmaceutical, Biopharmaceutical, Life Science, and Medical Device sectors. More than 300 Chinese institutional investors attended the two-day conference which showcased Maxim Group’s healthcare research coverage through a combination of company presentations, Q&A sessions, and management one on one meetings.

Michael Rabinowitz, Chairman & CEO of Maxim Group, added “Our commitment to build a first class healthcare practice has never wavered, and these promotions are another significant step in that process. As we continue our firm-wide expansion, we expect to add other high quality healthcare professionals to the Maxim Group research team.”

This entry was posted in 2017 News & Press, News and Press. Bookmark the permalink.